Watch Ticker

Cassava Sciences, Inc.

Go to Cassava Sciences, Inc. Website

$0.00

(%)

Live

Previous Close

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$874.9 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Cassava Sciences, Inc. - Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam

AUSTIN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today reported financial results for first quarter ended March 31, 2024. Net income was $25.0 million compared to a net loss of $24.3 million for the same period in 2023. Net cash used in operations was $19.1 million during the first quarter of 2024. Cash use for operations for the first half of 2024 is still expected to be $35 to $45 million, driven primarily by expenses for our clinical program in Alzheimer’s disease.

Related tickers: SAVA.

Read Full Article

Cassava Sciences, Inc. - Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution

Gross Proceeds from Warrants Represents the Sale of Approximately 5.7 Million Shares Of Common Stock At $22.00 Per Share Gross Proceeds from Warrants Represents the Sale of Approximately 5.7 Million Shares Of Common Stock At $22.00 Per Share

Related tickers: SAVA.

Read Full Article

Trending Tickers

AMBO

XASE

$1.35

0.03 (2.67%)

LASE

XNAS

$2.62

0.22 (9.17%)

SMFL

XNAS

$2.92

-0.43 (-12.84%)

BFRG

XNAS

$2.81

-0.08 (-2.71%)

MLGO

XNAS

$2.30

0.04 (1.77%)